Tech Company Financing Transactions
Sopherion Therapeutics Funding Round
On 12/31/2009, Sopherion Therapeutics landed $2.6 million in funding from Canaan Partners, TL Ventures and private investors.
Transaction Overview
Company Name
Announced On
12/31/2009
Transaction Type
Venture Equity
Amount
$2,600,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
104 Carnegie Center 200
Princeton, NJ 08540
USA
Princeton, NJ 08540
USA
Phone
Website
Email Address
Overview
Sopherion Therapeutics, Inc. is a biopharmaceutical company focusing on the development and commercialization of anti-cancer therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ronald Goldfarb
Executive Vice President
Marcel Rozencweig
VP - Finance
Alina Groblicka
VP - Regulatory Affairs
Salvatore Forenza
Browse more venture capital transactions:
Prev: 12/31/2009: Axikin Pharmaceuticals venture capital transaction
Next: 12/31/2009: Bluefin Labs venture capital transaction
Share this article
About Our VC Transactions Data
We report on every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs